GPSS

Affyn Races into Grand Prix Season Singapore 2023 Partnership

Retrieved on: 
Monday, August 14, 2023
Metaverse, Suntec City, Singapore Tourism Board, NFT, 1937 Grand Prix season, Exhibition, STB, Synthesis, GPSS, Web 3.0, Talk, Web 2.0

Singapore, Singapore--(Newsfile Corp. - August 14, 2023) - Affyn is partnering with the Grand Prix Season Singapore 2023 (GPSS), an event supported by the Singapore Tourism Board, to present a Web 3.0 event during the week of the Formula One Singapore Grand Prix.

Key Points: 
  • Singapore, Singapore--(Newsfile Corp. - August 14, 2023) - Affyn is partnering with the Grand Prix Season Singapore 2023 (GPSS), an event supported by the Singapore Tourism Board, to present a Web 3.0 event during the week of the Formula One Singapore Grand Prix.
  • Affyn is proud to be a part of this momentous occasion, which serves as a testament to our commitment to innovation, as well as the company's aim to help make Singapore a destination for future-facing developments.
  • Affyn CEO, Lucaz Lee, said: "We are proud to partner with GPSS, as it underlines Affyn's intent to bolster Government initiatives and bring Web 3.0 development to the next level.
  • As the only official Web 3.0 company partnering with GPSS, an event supported by STB, it is an incredible opportunity to drive awareness of developments in the industry.

Calgary cleantech company discovers process to produce fullerenes at scale

Retrieved on: 
Thursday, June 15, 2023
Carbon, Science, Fullerene, Civilization, AB, Health, Thermoelectric effect, USD, GPSS, Environment, Smoke, Renewable energy, Agriculture

This discovery will fundamentally accelerate the pace of innovation and global efforts towards building a sustainable and economically prosperous future.

Key Points: 
  • This discovery will fundamentally accelerate the pace of innovation and global efforts towards building a sustainable and economically prosperous future.
  • Their value is derived from the opportunities they unlock, and their proven ability to accelerate and heighten the capabilities of existing technologies.
  • "500,000 years ago, the discovery of fire changed civilization forever," said Blair Aiken, Chairman and Co-founder of Rain Cage Carbon.
  • En masse production to bring immeasurable social, economic and cultural impact
    While fullerenes have been known to science since 1985, the ability to harness and produce them at scale has been elusive.

Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update

Retrieved on: 
Tuesday, November 1, 2022
Security (finance), Marketing, MRSA, Clostridioides, DNA, Infection, IIIC, Clostridioides difficile (bacteria), Securities and Exchange Commission (Philippines), Annual report, Methicillin-resistant Staphylococcus aureus, Gram, VRE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Gram-positive bacteria, CDI, Maintenance, GAIN, Private Securities Litigation Reform Act, Company, Clostridioides difficile infection, FDA, Enterococcus, Patient, Food, Fast Track, QIDP, CDC, Act, Firmicutes, GPSS, DRSP, Pharmaceutical industry, Actinobacteria

It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.

Key Points: 
  • It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.
  • The Company successfully completed Phase 1 and Phase 2a clinical trials of ibezapolstat.
  • The CDC has designated C. difficile as an urgent threat highlighting the need for new antibiotics to treat CDI.
  • Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Asia's First Hybrid Online to Offline Festival to Bring Sim Racers and Entertainers Rriley and Haneri to Scape

Retrieved on: 
Monday, August 29, 2022
Singapore Tourism Board, Legion, Gamemaster, McLaren, Technology, The Sam Willows, Orchard Road, Formula, Augmented reality, Collection, HDC, Championship, Non-fungible token, Monster Energy, City, DJ, Logitech, GPSS, Hotel, Mobile phone, Amusement arcade, Nightclub, Entertainment

To be held at Orchard Road, this will be Asia's first hybrid online to offline festival that combines live sim racing, entertainment, lifestyle and technology within an urban carnival setting.

Key Points: 
  • To be held at Orchard Road, this will be Asia's first hybrid online to offline festival that combines live sim racing, entertainment, lifestyle and technology within an urban carnival setting.
  • The HDC will take place during this year's Grand Prix Season Singapore (GPSS) from 23 September to 2 October.
  • The simulated track which the sim racers will be racing on is the Orchard Road Street Circuit, which was produced by the Legion of Racers team.
  • The HDC 2022 Festival is set to bring more than 5,000 members of the public to *SCAPE while thousands more will follow the HyperDrive Cities Championships live on Youtube.

Nine Mile Metals Commences EarthEx 1000 Line/kms HD Proprietary UAV Mag Survey Over the High Priority VMS Targets at Nine Mile Brook VMS Project

Retrieved on: 
Thursday, August 25, 2022
CSE, 3D, National instrument, Borehole, QA, UAV, VMS, Bathurst Mining Camp, Disclosure, FSE, Drone, Data analysis, HD, GLOBE, Company, News, Magnetism, GPSS, KQ9, OTCQB, LIDAR, Spruce Lake, Surveying

EarthEx Geophysical Solutions Inc. (EarthEX) has commenced a detailed UAV (Drone) high-definition proprietary technology based magnetic survey on the Nine Mile Brook VMS Project.

Key Points: 
  • EarthEx Geophysical Solutions Inc. (EarthEX) has commenced a detailed UAV (Drone) high-definition proprietary technology based magnetic survey on the Nine Mile Brook VMS Project.
  • Figure 1: EarthEX HD-UAV Survey Grid over VMS High Priority Targets, Nine Mile Brook VMS Project is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f0475d52-19ad-49f2-8...
    In Figure 1 above, the 1000 line kms survey block is outlined in yellow, covering high priority targets (1 -5), (7) and (13).
  • The UAV survey also covers the highly prospective Spruce Lake Formation volcanics which hosts target (5).
  • This newly proven advanced proprietary UAV Drone technology from EarthEX, just released last year, will define all geological structures within the grid over our identified high priority VMS targets.

Acurx Pharmaceuticals, Inc. to Discuss 2022 Second Quarter Financial Results on August 16, 2022 Conference Call and Provide Business Update

Retrieved on: 
Thursday, August 4, 2022
Fast Track, Private Securities Litigation Reform Act, Annual report, Security (finance), Marketing, GPSS, Gram, Clostridioides difficile (bacteria), CDI, IIIC, Patient, Food, MRSA, Company, Clostridioides, Infection, QIDP, Enterococcus, Securities and Exchange Commission (Philippines), FDA, Maintenance, Act, VRE, DRSP, GAIN, Firmicutes, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Clostridioides difficile infection, DNA, Methicillin-resistant Staphylococcus aureus, Gram-positive bacteria, CDC, Pharmaceutical industry, Actinobacteria

It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.

Key Points: 
  • It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.
  • The Company successfully completed Phase 1 and Phase 2a clinical trials of ibezapolstat.
  • Acurx is currently enrolling patients in its Phase 2b vancomycin-controlled efficacy study in a 1:1 randomized trial of a total of 64 patients with CDI.
  • Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Acurx Pharmaceuticals, Inc. to Discuss 2022 First Quarter Financial Results on May 11, 2022 Conference Call and Provide Business Update

Retrieved on: 
Friday, April 29, 2022
MRSA, QIDP, DNA, Securities and Exchange Commission (Philippines), Infection, Clostridioides, DRSP, Patient, Annual report, FDA, Clostridioides difficile (bacteria), GAIN, Enterococcus, Food, Gram-positive bacteria, Clostridioides difficile infection, Company, Act, Gram, Private Securities Litigation Reform Act, CDI, Security (finance), Marketing, CDC, VRE, Firmicutes, Methicillin-resistant Staphylococcus aureus, Fast Track, GPSS, IIIC, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Maintenance, Pharmaceutical industry, Actinobacteria

It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.

Key Points: 
  • It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.
  • The Company successfully completed Phase 1 and Phase 2a clinical trials of ibezapolstat.
  • Acurx is currently enrolling patients in its Phase 2b vancomycin-controlled efficacy study in a 1:1 randomized trial of a total of 64 patients with CDI.
  • Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

Acurx Pharmaceuticals to Discuss 2021 Third Quarter Financial Results on November 15, 2021 Conference Call and Provide Business Update

Retrieved on: 
Wednesday, October 27, 2021
DRSP, Medication, Gram, IIIC, Fast Track, Infection, Methicillin-resistant Staphylococcus aureus, Patient, NASDAQ, QIDP, FDA, Food, GPSS, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, VRE, Gram-positive bacteria, MRSA, Maintenance, Company, Clostridioides difficile (bacteria), CDC, Enterococcus, Clostridioides, Firmicutes, CDI, GAIN, Act, Actinobacteria, DNA, Pharmaceutical industry, Antibiotics

David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:

Key Points: 
  • David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:
    Ibezapolstat is a novel, orally administered antibiotic being developed as a Gram-Positive Selective Spectrum (GPSS) antibacterial.
  • It is the first of a new class of DNA polymerase IIIC inhibitors under development by Acurx to treat bacterial infections.
  • Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
  • To learn more about Acurx Pharmaceuticals and its product pipeline please visit www.acurxpharma.com .

Ekinops selected by Grosse Pointe School System to Build WDM Network

Retrieved on: 
Thursday, August 5, 2021
GPSS, Grosse Pointe, WDM, Grosse Pointe Public School System, Euronext Paris, Interview, Student, Limited liability company, Michigan, District, Technology, Plante Moran, Mobile phone

ROCKVILLE, Md., Aug. 5, 2021 /PRNewswire/ -- Ekinops (Euronext Paris - FR0011466069 – EKI), a leading supplier of advanced optical transport systems and access network solutions for service providers and enterprises, today announces that the Grosse Pointe (Michigan) School System (GPSS) has selected its Ekinops360 optical transport system to build a new wavelength division multiplexing (WDM) network in its district.

Key Points: 
  • (Euronext Paris - FR0011466069 EKI), a leading supplier of advanced optical transport systems and access network solutions for service providers and enterprises, today announces that the Grosse Pointe (Michigan) School System (GPSS) has selected its Ekinops360 optical transport system to build a new wavelength division multiplexing (WDM) network in its district.
  • GPSS selected the Ekinops360 after a competitive, open bid process that attracted multiple proposals from the global WDM system vendor community.
  • After considering several alternatives, GPSS made the decision to build its own WDM network.
  • "Grosse Pointe is yet another example of how Ekinops is able to serve customers outside of our traditional telco and service provider markets," saidKevin Antill, Ekinops' group vice president of sales for North America.